AVXL has been in the news 395% more than usual
Dec 12, 2024, 11:31 PM
35.30%
What does AVXL do
Anavex Life Sciences, a New York-based biopharmaceutical company, develops therapeutics for neurodegenerative diseases and employs 40 staff. Its lead compound, ANAVEX 2-73, targets Alzheimer's and Parkinson's diseases.
AVXL has been in the news recently: Oaktree Acquisition Corp. III Life Sciences will permit unit holders to trade shares and warrants separately starting December 16, 2024. Additionally, QIAGEN has introduced IPA Interpret, an AI-driven tool designed to simplify biological data interpretation and enhance insights for research in the life sciences.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.